propafenone has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 24 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this prospective, non-randomized interventional study was to assess electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia (AVNRT) and orthodromic atrioventricular reentrant tachycardia (AVRT)." | 9.14 | Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study. ( Delić-Brkljacić, D; Manola, S; Nossan, JS; Pavlović, N; Pintarić, H; Radeljić, V, 2010) |
| "The antiarrhythmic agent propafenone has been reported to prolong atrioventricular node conduction and may be suitable for rate control in atrial fibrillation (AF)." | 9.07 | The inefficacy of intravenous propafenone for rate control in atrial fibrillation. ( Klein, GJ; Leather, RA; Leitch, JW; Murdoch, C; Yee, R, 1994) |
| "We compared the electrophysiological effects of intravenous propafenone and flecainide on accessory pathway conduction by a randomized crossover study in 16 patients with Wolff-Parkinson-White syndrome." | 9.07 | A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. ( Camm, AJ; Garratt, CJ; Gill, J; Linker, NJ; O'Nunain, S; Ward, DE, 1991) |
| "The efficacy and safety of intravenous propafenone was studied in 10 patients with Wolff-Parkinson-White syndrome and in 2 patients with a concealed accessory pathway." | 9.06 | Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. ( Antman, EM; Friedman, PL; Ludmer, PL; McGowan, NE, 1987) |
| "Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function." | 7.85 | Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017) |
| "The electrophysiologic effects of diprafenone were evaluated in 31 patients (9 X AV nodal reentrant tachycardia, 9 X Wolff-Parkinson-White syndrome, 4 X paroxysmal atrial fibrillation, 10 X recurrent ventricular tachycardia)." | 7.67 | [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. ( Beermann, J; Gerckens, U; Lüderitz, B; Manz, M, 1986) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 5.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| "The antiarrhythmic agent propafenone has been reported to prolong atrioventricular node conduction and may be suitable for rate control in atrial fibrillation (AF)." | 5.07 | The inefficacy of intravenous propafenone for rate control in atrial fibrillation. ( Klein, GJ; Leather, RA; Leitch, JW; Murdoch, C; Yee, R, 1994) |
| "We compared the electrophysiological effects of intravenous propafenone and flecainide on accessory pathway conduction by a randomized crossover study in 16 patients with Wolff-Parkinson-White syndrome." | 5.07 | A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. ( Camm, AJ; Garratt, CJ; Gill, J; Linker, NJ; O'Nunain, S; Ward, DE, 1991) |
| "The efficacy and safety of intravenous propafenone was studied in 10 patients with Wolff-Parkinson-White syndrome and in 2 patients with a concealed accessory pathway." | 5.06 | Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. ( Antman, EM; Friedman, PL; Ludmer, PL; McGowan, NE, 1987) |
| "Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function." | 3.85 | Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017) |
| "To assess the efficacy of propafenone in prevention of atrioventricular nodal reentrant tachycardia (AVNRT) and orthodromic atrioventricular tachycardia (AVRT) based on the clinical results of arrhythmia recurrence and find the electrophysiological predictor of propafenone effectiveness." | 3.78 | Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia. ( Babić, Z; Bosnjak, H; Pavlović, N; Petrac, D; Pintarić, H; Vrsalović, M; Zeljković, I, 2012) |
| "The electrophysiologic effects of diprafenone were evaluated in 31 patients (9 X AV nodal reentrant tachycardia, 9 X Wolff-Parkinson-White syndrome, 4 X paroxysmal atrial fibrillation, 10 X recurrent ventricular tachycardia)." | 3.67 | [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. ( Beermann, J; Gerckens, U; Lüderitz, B; Manz, M, 1986) |
| " Little justification for the use of agents or dosing in children is available." | 2.40 | Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. ( Kuhn, RJ; Luedtke, SA; McCaffrey, FM, 1997) |
| "Propafenone has little effects on sinus node." | 1.30 | [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique]. ( Li, Q; Peng, D; Wang, Z, 1997) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 1.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| " The same holds true for general tolerance: in 2 cases drug administration is discontinued and 11 patients present neurologic and digestive troubles improving after lowering the dosage or increasing the fractionation." | 1.27 | [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation]. ( Cosnay, P; Fauchier, JP; Kapusta, P; Moquet, B; Rouesnel, P; Vrancea, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 11 (45.83) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Zhang, Y | 2 |
| Liu, H | 1 |
| Jiang, H | 1 |
| Ge, H | 1 |
| Khavandi, A | 1 |
| Walker, SK | 1 |
| Pintarić, H | 2 |
| Manola, S | 1 |
| Nossan, JS | 1 |
| Pavlović, N | 2 |
| Delić-Brkljacić, D | 1 |
| Radeljić, V | 1 |
| Ardashev, AV | 1 |
| Zheliakov, EG | 1 |
| Zeljković, I | 1 |
| Babić, Z | 1 |
| Vrsalović, M | 1 |
| Bosnjak, H | 1 |
| Petrac, D | 1 |
| Slivnjak, V | 1 |
| Vrljić, D | 1 |
| Lakusić, N | 1 |
| Koshumbaeva, KM | 1 |
| Belokopit, IN | 1 |
| Makhanov, DI | 1 |
| Nugmanova, MN | 1 |
| Heusch, A | 1 |
| Kramer, HH | 1 |
| Krogmann, ON | 1 |
| Rammos, S | 1 |
| Bourgeous, M | 1 |
| Chen, X | 1 |
| Borggrefe, M | 1 |
| Martinez-Rubio, A | 1 |
| Hief, C | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Breithardt, G | 1 |
| Gutiérrez-Larraya, F | 1 |
| Jabón, A | 1 |
| Leather, RA | 1 |
| Klein, GJ | 1 |
| Murdoch, C | 1 |
| Yee, R | 1 |
| Leitch, JW | 1 |
| Mannino, MM | 1 |
| Mehta, D | 1 |
| Gomes, JA | 1 |
| Luedtke, SA | 1 |
| Kuhn, RJ | 1 |
| McCaffrey, FM | 1 |
| Müller, U | 1 |
| Jochheim, R | 1 |
| Knaup, W | 1 |
| Tenholt, M | 1 |
| Li, Q | 1 |
| Wang, Z | 1 |
| Peng, D | 1 |
| Hessling, G | 1 |
| Brockmeier, K | 1 |
| Ruediger, HJ | 1 |
| Ulmer, HE | 1 |
| Shi, L | 1 |
| Qian, JA | 1 |
| Qi, WH | 1 |
| O'Nunain, S | 1 |
| Garratt, CJ | 1 |
| Linker, NJ | 1 |
| Gill, J | 1 |
| Ward, DE | 1 |
| Camm, AJ | 1 |
| Wu, Z | 1 |
| Fauchier, JP | 1 |
| Cosnay, P | 1 |
| Moquet, B | 1 |
| Rouesnel, P | 1 |
| Kapusta, P | 1 |
| Vrancea, F | 1 |
| Allen, BJ | 1 |
| Brodsky, MA | 1 |
| Doria, R | 1 |
| Luckett, CR | 1 |
| Thomas, R | 1 |
| Henry, WL | 1 |
| Ludmer, PL | 1 |
| McGowan, NE | 1 |
| Antman, EM | 1 |
| Friedman, PL | 1 |
| Dirix, LY | 1 |
| Moeremans, C | 1 |
| Fierens, H | 1 |
| Dielen, D | 1 |
| Vrints, C | 1 |
| Van Agt, E | 1 |
| Snoeck, J | 1 |
| Manz, M | 1 |
| Beermann, J | 1 |
| Gerckens, U | 1 |
| Lüderitz, B | 1 |
3 reviews available for propafenone and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
[Atrioventricular nodal reciprocal tachycardia: classification, clinical manifestations, diagnosis, and treatment].
Topics: Anti-Arrhythmia Agents; Calcium Channel Blockers; Catheter Ablation; Diagnosis, Differential; Electr | 2010 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Ch | 1997 |
6 trials available for propafenone and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Electrophysiologic Techniques, Cardiac; Female; Hum | 2010 |
Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
Topics: Accessory Nerve; Adolescent; Adult; Aged; Ajmaline; Atrial Fibrillation; Electrophysiology; Female; | 1994 |
The inefficacy of intravenous propafenone for rate control in atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Blood Pressure; Electrocardiography; Female; Humans; Infusions, In | 1994 |
Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children.
Topics: Adolescent; Age Factors; Anti-Arrhythmia Agents; Child; Child, Preschool; Dose-Response Relationship | 2001 |
A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Flecainide; Humans; Male; Propafenon | 1991 |
Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Topics: Adolescent; Adult; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Female; Follow- | 1987 |
15 other studies available for propafenone and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Dr | 2017 |
Atrial tachycardia with 1:1 atrioventricular conduction precipitated by propafenone.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle of His; Electric Countershock; Electrocardiograp | 2009 |
Electrophysiological predictors of propafenone efficacy in prevention of atrioventricular nodal re-entrant and atrioventricular re-entrant tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Electrocardiography; Electrophysiologic | 2012 |
Arrhythmogenic effect of propafenone administered for a "wrong" clinical diagnosis.
Topics: Anti-Arrhythmia Agents; Female; Humans; Male; Propafenone; Tachycardia, Atrioventricular Nodal Reent | 2012 |
[Preventive efficacy of propafenone, its effect on functional state of the heart during long-term treatment of patients with paroxysmal atrioventricular arrhythmias].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Follow-Up Studies; Hea | 2006 |
Clinical experience with propafenone for cardiac arrhythmias in the young.
Topics: Administration, Oral; Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature | 1994 |
Current treatment options for paroxysmal supraventricular tachycardia.
Topics: Acute Disease; Catheter Ablation; Chronic Disease; Flecainide; Humans; Propafenone; Tachycardia, Atr | 1994 |
[Implantable event recorder: a new aid for the diagnosis of arrhythmogenic syncope].
Topics: Anti-Arrhythmia Agents; Atrial Premature Complexes; Digitalis Glycosides; Drug Eruptions; Electrocar | 1998 |
[The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Electr | 1997 |
[Electrophysiological effects of intravenous propafenone for treating atrial-ventricular nodal dual pathways reentrant tachycardia].
Topics: Adult; Aged; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafen | 1992 |
[Clinical electrophysiologic study in paroxysmal reentry tachycardia treated by rhythnorma].
Topics: Electrophysiology; Female; Heart; Humans; Male; Propafenone; Tachycardia, Atrioventricular Nodal Ree | 1990 |
[Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
Topics: Administration, Oral; Adult; Aged; Electrocardiography; Female; Humans; Injections, Intravenous; Mal | 1986 |
Oral propafenone therapy for patients with paroxysmal supraventricular tachyarrhythmia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Male; Mid | 1988 |
Symptomatic hyponatremia related to the use of propafenone.
Topics: Aged; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Propafenone; Tachycardia, Atrioventr | 1988 |
[Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle of His; Cardiomyopathy, Dilated; Coronary Diseas | 1986 |